Akira Kawamura to Treatment Outcome
This is a "connection" page, showing publications Akira Kawamura has written about Treatment Outcome.
Connection Strength
0.275
-
Nakamura M, Ike A, Kato Y, Futami M, Kuwano T, Sugihara M, Iwata A, Kawamura A, Suematsu Y, Miura SI. Differences in lesion characteristics and patient background associated with the medium-term clinical outcomes of bare-metal and first-, second- and third-generation drug-eluting stents. Heart Vessels. 2021 Feb; 36(2):211-222.
Score: 0.035
-
Matsuoka Y, Ike A, Ogawa M, Gondo K, Shirai K, Sugihara M, Nose D, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Yasunaga S, Miura SI, Saku K. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry. J Cardiol. 2018 03; 71(3):259-267.
Score: 0.028
-
Ike A, Shirai K, Nishikawa H, Iwata A, Yahiro E, Sugihara M, Kawamura A, Uehara Y, Zhang B, Ogawa M, Mori K, Miura S, Saku K. Associations between different types of hypoglycemic agents and the clinical outcome of percutaneous coronary intervention in diabetic patients-From the FU-Registry. J Cardiol. 2015 May; 65(5):390-6.
Score: 0.023
-
Morii J, Miura S, Ike A, Shiga Y, Sugihara M, Iwata A, Kawamura A, Nishikawa H, Saku K. Comparison of the efficacies of irbesartan and olmesartan after successful coronary stent implantation. Intern Med. 2013; 52(7):713-9.
Score: 0.021
-
Sugihara M, Miura S, Nishikawa H, Ike A, Mori K, Iwata A, Kawamura A, Saku K. Characteristics of patients and types of lesions in patients with drug-eluting or bare-metal stent implantation in small coronary arteries: from the FU-Registry. J Cardiol. 2013 Feb; 61(2):117-21.
Score: 0.020
-
Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis. 2012 Aug; 23(5):315-21.
Score: 0.020
-
Arimura T, Miura S, Ike A, Sugihara M, Iwata A, Nishikawa H, Kawamura A, Saku K. Comparison of the efficacy and safety of statin and statin/ezetimibe therapy after coronary stent implantation in patients with stable angina. J Cardiol. 2012 Aug; 60(2):111-8.
Score: 0.019
-
Ike A, Shirai K, Nishikawa H, Zhang B, Kawamura A, Iwata A, Mori K, Ogawa M, Miura S, Noda K, Saku K. [Series: clinical study from Japan and its reflections; impact of glycemic control on the clinical outcome in diabetic patients with percutaneous coronary intervention:--from the FU-registry--(UMIN registration no. 000005679)]. Nihon Naika Gakkai Zasshi. 2012 Feb 10; 101(2):504-11.
Score: 0.019
-
Mito T, Miura S, Iwata A, Morii J, Sugihara M, Ike A, Mori K, Kawamura A, Nishikawa H, Zhang B, Saku K. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina. Coron Artery Dis. 2011 Nov; 22(7):451-7.
Score: 0.019
-
Arimura T, Mitsutake R, Miura S, Nishikawa H, Kawamura A, Saku K. Acute myocardial infarction associated with pregnancy successfully treated with percutaneous coronary intervention. Intern Med. 2009; 48(16):1383-6.
Score: 0.016
-
Takamiya Y, Miura S, Kawamura A, Tanigawa H, Zhang B, Iwata A, Nishikawa H, Matsuo K, Shirai K, Saku K. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease. Coron Artery Dis. 2009 Jun; 20(4):288-94.
Score: 0.016
-
Yanagi D, Shirai K, Takamiya Y, Fukuda Y, Kuwano T, Ike A, Mori K, Kubota K, Iwata A, Fujimi K, Kawamura A, Nishikawa H, Miller N, Zhang B, Tsuchiya Y, Urata H, Saku K. Results of provisional stenting with a Sirolimus-eluting stent for bifurcation lesion: multicenter study in Japan. J Cardiol. 2008 Apr; 51(2):89-94.
Score: 0.015
-
Mitsutake R, Miura S, Okamura K, Niimura H, Kawamura A, Saku K. Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography. Intern Med. 2007; 46(12):859-63.
Score: 0.014
-
Komazawa Y, Adachi K, Mihara T, Ono M, Kawamura A, Fujishiro H, Kinoshita Y. Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J Gastroenterol Hepatol. 2003 Jun; 18(6):678-82.
Score: 0.010